What is it about?

Bisoprolol may be associated with reduced cardiac events compared to carvedilol among patients with concurrent heart failure with reduced ejection fraction and chronic kidney disease.

Featured Image

Read the Original

This page is a summary of: Comparative Effectiveness of Bisoprolol, Carvedilol, and Metoprolol Succinate in Patients with Heart Failure and Chronic Kidney Disease, Clinical Journal of the American Society of Nephrology, September 2024, Wolters Kluwer Health,
DOI: 10.2215/cjn.0000000000000562.
You can read the full text:

Read

Contributors

The following have contributed to this page